Changing The Game With The Echo Exam: Philips Ultrasound

On The ESC Agenda: The Evolving Ultrasound Market And Integrating Israeli Company DiA

On the eve of the 2023 European Society of Cardiology meeting, senior Philips ultrasound directors spoke to In Vivo about the company’s strategies to maintain cardiac market leadership, building on internal and externally acquired strengths and evolving attitudes to AI in product development and use.

LinkedIn Philips at ESC
Philips' Dave Handler at ESC 2023, Amsterdam • Source: Philips ESC LinkedIn video

Cardiovascular disease applications represent upwards of €1bn ($1.1bn) of the ultrasound market. Royal Philips is number one globally in this segment, but Jeff Cohen, the company’s global general manager of ultrasound, insists that there is always work to do to ensure market supremacy is maintained.

Speaking to In Vivo during the company’s final preparations for the 2023 European Society of Cardiology (ESC) conference in Amsterdam,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

More from In Vivo